Experience of immune-related adverse events associated with anti-CTLA-4 and anti-PD1 checkpoint inhibitors in a single center

被引：0
|
作者：
Rapoport, B. L. [1 ]
Smit, T. [1 ]
Van Eeden, R. I. [1 ]
机构：
[1] Med Oncol Ctr Rosebank, Med Oncol, Johannesburg, South Africa
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
24P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Durable remissions associated with anti-CTLA-4 and anti-PD1 checkpoint inhibitors in a single center
    Smit, T.
    Rapoport, B. L.
    Van Eeden, R. I.
    ANNALS OF ONCOLOGY, 2017, 28
  • [2] Immune-related adverse events of anti-PD-1 immune checkpoint inhibitors: a single center experience
    Sebestyen, Eniko
    Major, Nora
    Bodoki, Levente
    Makai, Attila
    Balogh, Ingrid
    Toth, Gabor
    Orosz, Zsuzsanna
    Arkosy, Peter
    Vasko, Attila
    Hodosi, Katalin
    Szekanecz, Zoltan
    Szekanecz, Eva
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [3] Safety of resuming anti-PD-1 in patients with immune-related adverse events (irAEs) during combined anti-CTLA-4 and anti-PD1 in metastatic melanoma
    Pollack, M. H.
    Betof, A.
    Dearden, H.
    Rapazzo, K.
    Valentine, I.
    Brohl, A. S.
    Ancell, K. K.
    Long, G. V.
    Menzies, A. M.
    Eroglu, Z.
    Johnson, D. B.
    Shoushtari, A. N.
    ANNALS OF ONCOLOGY, 2018, 29 (01) : 250 - 255
  • [4] Immune-related adverse events associated with immune-checkpoint inhibitors: A single center experience
    Samanci, N. S.
    Oruc, K.
    Bedir, S.
    Celik, E.
    Degerli, E.
    Derin, S.
    Demirelli, F. H.
    Ozguroglu, M.
    ANNALS OF ONCOLOGY, 2019, 30
  • [5] Colon Immune-Related Adverse Events: Anti-CTLA-4 and Anti-PD-1 Blockade Induce Distinct Immunopathological Entities
    Coutzac, Clelia
    Adam, Julien
    Soularue, Emilie
    Collins, Michael
    Racine, Antoine
    Mussini, Charlotte
    Boselli, Lisa
    Kamsukom, Nyam
    Mateus, Christine
    Charrier, Melinda
    Cassard, Lydie
    Planchard, David
    Ribrag, Vincent
    Fizazi, Karim
    Loriot, Yohann
    Lepage, Patricia
    Scoazec, Jean-Yves
    Robert, Caroline
    Carbonnel, Franck
    Chaput, Nathalie
    JOURNAL OF CROHNS & COLITIS, 2017, 11 (10): : 1238 - 1246
  • [6] Thyroid Immune-Related Adverse Events in Patients with Cancer Treated with anti-PD1/anti-CTLA4 Immune Checkpoint Inhibitor Combination: Clinical Course and Outcomes
    Lui, David Tak Wai
    Lee, Chi Ho
    Tang, Vikki
    Fong, Carol Ho Yi
    Lee, Alan Chun Hong
    Chiu, Joanne Wing Yan
    Leung, Roland Ching Yu
    Kwok, Gerry Gin Wai
    Li, Bryan Cho Wing
    Cheung, Tan To
    Woo, Yu Cho
    Lam, Karen Siu Ling
    Yau, Thomas
    ENDOCRINE PRACTICE, 2021, 27 (09) : 886 - 893
  • [7] A single center experience with neuromuscular immune-related adverse events of immune checkpoint inhibitors
    Moreno Lopez, C.
    Chico Garcia, J.
    Martinez Garcia, B.
    Garcia Alcantara, G.
    Lopez Rebolledo, R.
    Cabanas Engenios, G.
    Corral Corral, I.
    Alvarez Velasco, R.
    Buisan Catevilla, F.
    Garcia Barragan, N.
    Zarza Sanz, B.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 468 - 468
  • [8] Physiopathological mechanisms of immune-related adverse events induced by anti-CTLA-4, anti-PD-1 and anti-PD-L1 antibodies in cancer treatment
    Passat, Tilda
    Touchefeu, Yann
    Gervois, Nadine
    Jarry, Anne
    Bossard, Celine
    Bennouna, Jaafar
    BULLETIN DU CANCER, 2018, 105 (11) : 1033 - 1041
  • [9] Hepatic and digestive adverse events of immune checkpoint inhibitors (anti-CTLA-4 and, anti-PD-1/PD-L1): A clinico-pathological review
    Papouin, Barbara
    Mussini, Charlotte
    De Martin, Eleonora
    Guettier, Catherine
    ANNALES DE PATHOLOGIE, 2018, 38 (06) : 338 - 351
  • [10] Abscopal Effect in Patients With Metastatic Melanoma Treated With Checkpoint Inhibitors (Anti-CTLA-4 and Anti-PD1): A Retrospective Analysis of a Single Institution
    Carvalho, R. F.
    Ferrigno, R.
    Marotta, R. C.
    Amarantes, M. P. F.
    Schmerling, R. A.
    Haddad, C. K.
    Gil, E.
    Moraes, P. L.
    Zanuncio, P. H.
    Buzaid, A. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S159 - S159
12345